A significant breakthrough in cancer investigation is arising with the use of VHH fragments to restore mutated p53. This essential cancer inhibitor protein is frequently inactivated in many forms of cancer, causing https://social-medialink.com/story7015323/mini-antibodies-reactivate-p53-the-potential-hope-for-cancer-management